Dislog Medical Devices: a new Moroccan Leader in Medical Devices

Dislog Group has reached a major strategic milestone in its diversification strategy by launching Dislog Medical Devices (DMD), a new entity bringing together six specialized subsidiaries: Megaflex, Afrobiomedic, Farmalac, Eramedic, Promedstore Imaging, and Scomedica. This build-up project reflects the Group’s firm commitment to establishing a strong and lasting presence in the medical devices sector, an industry with high growth potential and significant impact.

An Ambitious and Structured Consolidation

Key structuring operations already completed include:

• A fundraising of 700 million dirhams to support DMD’s development in Morocco and abroad over the next two years.

• A 11% equity stake granted to the founding management teams of the six integrated companies.

• The acquisition of 100% of Megaflex, following the buyout of the remaining 22% held by its founder, Nacer Amrani.

• The full takeover of Scomedica through the buyout of shares held by Dr. Ali Squalli.

• The appointment of Mehdi Bouamrani as Chairman of the Board and Karim Hajj Riffi as CEO.

• The establishment of a strategic steering committee made up of Mehdi Bouamrani and shareholder-directors: Karim Hajj (Eramedic), Driss Nasr (Afrobiomedic), Mounir Serifi (Farmalac), and Dr. Ali Squalli (Scomedica).

• A unified organizational chart, while keeping the founders at the helm of each subsidiary.

• An integration seminar held yesterday, bringing together 250 employees from the subsidiaries to foster alignment around DMD’s vision and a shared goal: achieving 2 billion dirhams in revenue by 2028.

Strong Financial Backing for Continental Ambitions

The operation is supported by substantial financing:

• MCP and CDG Invest Growth jointly inject 540 million dirhams, representing 35% of the capital.

• The founders of the integrated entities contribute 190 million dirhams, representing 11% of the capital.

• Dislog Group retains majority ownership and operational control, with a strong financial commitment of 700 million dirhams in cash, earmarked to accelerate DMD’s growth.

Dislog Medical Devices is now positioned as an integrated platform dedicated to the design, manufacturing, and distribution of single-use medical devices. Leveraging local expertise and an active scientific network, DMD addresses the growing needs of the Moroccan and regional markets while contributing to the Kingdom’s healthcare sovereignty.

With 1.1 billion dirhams in revenue, 250 employees, and a commercial presence in more than 65 countries, DMD already ranks as the third-largest Moroccan player in the sector. Its ambition: to become a “One Stop Shop” for healthcare in Morocco, offering integrated solutions across the entire value chain and covering all therapeutic areas.

Focus on 2025 and Africa

International expansion has already begun with the opening of a first subsidiary in Tunis, marking the start of the Group’s growth across the African continent.

A major milestone is set for Arab Health 2026 in Dubai, where DMD will unveil its detailed African strategy and long-term ambitions.

About Dislog Group

Founded in 2005, Dislog Group is an integrated and diversified Moroccan industrial group. A Moroccan leader in FMCG and, more recently, in pharmaceuticals, Dislog Group operates in three key life economy sectors: hygiene, food, and healthcare. Its industrial units in Morocco and Europe manufacture and market the following products:

• Hygiene sector: liquid detergents, multi-purpose and specialized cleaning products, bleach, paper hygiene products, baby diapers.

• Healthcare sector: medical devices (infusion, injection, and hospital care products, rapid tests, reagents, and laboratory equipment), multi-form pharmaceuticals (capsules, tablets, syrups), and dermo-cosmetics (creams and body care products).

• Food sector: chocolates, biscuits, confectionery, and organic food products (soups, sauces, juices).

With 200 brands, both owned and partnered, Dislog Group improves the daily lives of consumers in Morocco and Europe.

The Group employs 3,600 people and has developed a portfolio of hundreds of brands that enhance households’ and consumers’ daily lives.

It has become a market leader in just 15 years thanks to its vision of developing brands in the life economy and its positioning as a “Full Service Provider”, integrating the entire value chain through its various subsidiaries—from production to the end consumer.

About Dislog Medical Devices (DMD)

Dislog Medical Devices (DMD) is a national platform specializing in the design, manufacturing, and distribution of single-use medical devices. It encompasses the following subsidiaries: Megaflex, Afrobiomedic, Farmalac, Eramedic, Promedstore Imaging, and Scomedica.

• Megaflex specializes in the production of single-use medical devices, notably infusion, injection, and hospital care products. With internationally compliant production units, Megaflex actively reduces reliance on imports by offering reliable, affordable, locally made products.

• Afrobiomedic is an emerging player in medical diagnostics, developing and distributing innovative solutions in medical biology, including rapid tests, reagents, and laboratory equipment. Its mission: to strengthen screening and prevention capacities in Africa through proximity and efficiency.

• Farmalac focuses on producing high-quality generic medicines and dietary supplements. Its integrated pharmaceutical approach ensures safe, effective treatments accessible to the widest possible population.

• Eramedic provides a wide range of consumables and medical equipment for healthcare professionals. With its distribution network and tailored solutions, it plays a central role in supplying medical facilities across Africa.

• Scomedica specializes in innovative medical devices for surgery, rehabilitation, and specialized medicine, combining advanced technologies with adaptations to African market needs.

• Promedstore Imaging focuses on advanced medical imaging, developing and distributing innovative solutions for diagnostic imaging, interventional radiology, and advanced monitoring systems. With its scientific and technical expertise, Promedstore Imaging improves diagnostic precision and access to specialized care in Morocco and Africa.

DMD aims to meet the growing demand of the Moroccan and regional markets while contributing to the Kingdom’s healthcare sovereignty. With 1.1 billion dirhams in revenue, 250 employees, and a network of 65 international partners, DMD is already the third-largest national player in the sector.